Virus growth and antibody responses following respiratory tract infection of ferrets and mice with WT and P/V mutants of the paramyxovirus Simian Virus 5
Identifieur interne : 000905 ( Pmc/Checkpoint ); précédent : 000904; suivant : 000906Virus growth and antibody responses following respiratory tract infection of ferrets and mice with WT and P/V mutants of the paramyxovirus Simian Virus 5
Auteurs : Gerald A. Capraro [États-Unis] ; John B. Johnson [États-Unis] ; Nancy D. Kock [États-Unis] ; Griffith D. Parks [États-Unis]Source :
- Virology [ 0042-6822 ] ; 2008.
Abstract
P/V gene substitutions convert the non-cytopathic paramyxovirus Simian Virus 5 (SV5), which is a poor inducer of host cell responses in human tissue culture cells, into a mutant (P/V-CPI–) that induces high levels of apoptosis, interferon (IFN)-beta, and proinflammatory cytokines. However, the effect of SV5-P/V gene mutations on virus growth and adaptive immune responses in animals has not been determined. Here, we used two distinct animal model systems to test the hypothesis that SV5-P/V mutants which are more potent activators of innate responses in tissue culture will also elicit higher antiviral antibody responses. In mouse cells, in vitro studies identified a panel of SV5-P/V mutants that ranged in their ability to limit IFN responses. Intranasal infection of mice with these WT and P/V mutant viruses elicited equivalent anti-SV5 IgG responses at all doses tested, and viral titers recovered from the respiratory tract were indistinguishable. In primary cultures of ferret lung fibroblasts, WT rSV5 and P/V-CPI– viruses had phenotypes similar to those established in human cell lines, including differential induction of IFN secretion, IFN signaling and apoptosis. Intranasal infection of ferrets with a low dose of WT rSV5 elicited ~500 fold higher anti-SV5 serum IgG responses compared to the P/V-CPI– mutant, and this correlated with overall higher viral titers for the WT virus in tracheal tissues. There was a dose-dependent increase in antibody response to infection of ferrets with P/V-CPI–, but not with WT rSV5. Together our data indicate that WT rSV5 and P/V mutants can elicit distinct innate and adaptive immunity phenotypes in the ferret animal model system, but not in the mouse system. We present a model for the effect of P/V gene substitutions on SV5 growth and immune responses in vivo.
Url:
DOI: 10.1016/j.virol.2008.03.034
PubMed: 18456301
PubMed Central: 2574746
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
PMC:2574746Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Virus growth and antibody responses following respiratory tract infection of ferrets and mice with WT and P/V mutants of the paramyxovirus Simian Virus 5</title>
<author><name sortKey="Capraro, Gerald A" sort="Capraro, Gerald A" uniqKey="Capraro G" first="Gerald A." last="Capraro">Gerald A. Capraro</name>
<affiliation wicri:level="2"><nlm:aff id="A1">Department of Microbiology and Immunology, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157-1064, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Microbiology and Immunology, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157-1064</wicri:regionArea>
<placeName><region type="state">Caroline du Nord</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Johnson, John B" sort="Johnson, John B" uniqKey="Johnson J" first="John B." last="Johnson">John B. Johnson</name>
<affiliation wicri:level="2"><nlm:aff id="A1">Department of Microbiology and Immunology, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157-1064, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Microbiology and Immunology, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157-1064</wicri:regionArea>
<placeName><region type="state">Caroline du Nord</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Kock, Nancy D" sort="Kock, Nancy D" uniqKey="Kock N" first="Nancy D." last="Kock">Nancy D. Kock</name>
<affiliation wicri:level="2"><nlm:aff id="A2">Department of Pathology/Comparative Medicine, Wake Forest University School of Medicine, Winston-Salem, NC 27157-1064, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Pathology/Comparative Medicine, Wake Forest University School of Medicine, Winston-Salem, NC 27157-1064</wicri:regionArea>
<placeName><region type="state">Caroline du Nord</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Parks, Griffith D" sort="Parks, Griffith D" uniqKey="Parks G" first="Griffith D." last="Parks">Griffith D. Parks</name>
<affiliation wicri:level="2"><nlm:aff id="A1">Department of Microbiology and Immunology, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157-1064, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Microbiology and Immunology, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157-1064</wicri:regionArea>
<placeName><region type="state">Caroline du Nord</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">18456301</idno>
<idno type="pmc">2574746</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2574746</idno>
<idno type="RBID">PMC:2574746</idno>
<idno type="doi">10.1016/j.virol.2008.03.034</idno>
<date when="2008">2008</date>
<idno type="wicri:Area/Pmc/Corpus">000630</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000630</idno>
<idno type="wicri:Area/Pmc/Curation">000630</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000630</idno>
<idno type="wicri:Area/Pmc/Checkpoint">000905</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000905</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Virus growth and antibody responses following respiratory tract infection of ferrets and mice with WT and P/V mutants of the paramyxovirus Simian Virus 5</title>
<author><name sortKey="Capraro, Gerald A" sort="Capraro, Gerald A" uniqKey="Capraro G" first="Gerald A." last="Capraro">Gerald A. Capraro</name>
<affiliation wicri:level="2"><nlm:aff id="A1">Department of Microbiology and Immunology, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157-1064, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Microbiology and Immunology, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157-1064</wicri:regionArea>
<placeName><region type="state">Caroline du Nord</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Johnson, John B" sort="Johnson, John B" uniqKey="Johnson J" first="John B." last="Johnson">John B. Johnson</name>
<affiliation wicri:level="2"><nlm:aff id="A1">Department of Microbiology and Immunology, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157-1064, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Microbiology and Immunology, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157-1064</wicri:regionArea>
<placeName><region type="state">Caroline du Nord</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Kock, Nancy D" sort="Kock, Nancy D" uniqKey="Kock N" first="Nancy D." last="Kock">Nancy D. Kock</name>
<affiliation wicri:level="2"><nlm:aff id="A2">Department of Pathology/Comparative Medicine, Wake Forest University School of Medicine, Winston-Salem, NC 27157-1064, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Pathology/Comparative Medicine, Wake Forest University School of Medicine, Winston-Salem, NC 27157-1064</wicri:regionArea>
<placeName><region type="state">Caroline du Nord</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Parks, Griffith D" sort="Parks, Griffith D" uniqKey="Parks G" first="Griffith D." last="Parks">Griffith D. Parks</name>
<affiliation wicri:level="2"><nlm:aff id="A1">Department of Microbiology and Immunology, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157-1064, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Microbiology and Immunology, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157-1064</wicri:regionArea>
<placeName><region type="state">Caroline du Nord</region>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j">Virology</title>
<idno type="ISSN">0042-6822</idno>
<idno type="eISSN">1096-0341</idno>
<imprint><date when="2008">2008</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p id="P1">P/V gene substitutions convert the non-cytopathic paramyxovirus Simian Virus 5 (SV5), which is a poor inducer of host cell responses in human tissue culture cells, into a mutant (P/V-CPI–) that induces high levels of apoptosis, interferon (IFN)-beta, and proinflammatory cytokines. However, the effect of SV5-P/V gene mutations on virus growth and adaptive immune responses in animals has not been determined. Here, we used two distinct animal model systems to test the hypothesis that SV5-P/V mutants which are more potent activators of innate responses in tissue culture will also elicit higher antiviral antibody responses. In mouse cells, in vitro studies identified a panel of SV5-P/V mutants that ranged in their ability to limit IFN responses. Intranasal infection of mice with these WT and P/V mutant viruses elicited equivalent anti-SV5 IgG responses at all doses tested, and viral titers recovered from the respiratory tract were indistinguishable. In primary cultures of ferret lung fibroblasts, WT rSV5 and P/V-CPI– viruses had phenotypes similar to those established in human cell lines, including differential induction of IFN secretion, IFN signaling and apoptosis. Intranasal infection of ferrets with a low dose of WT rSV5 elicited ~500 fold higher anti-SV5 serum IgG responses compared to the P/V-CPI– mutant, and this correlated with overall higher viral titers for the WT virus in tracheal tissues. There was a dose-dependent increase in antibody response to infection of ferrets with P/V-CPI–, but not with WT rSV5. Together our data indicate that WT rSV5 and P/V mutants can elicit distinct innate and adaptive immunity phenotypes in the ferret animal model system, but not in the mouse system. We present a model for the effect of P/V gene substitutions on SV5 growth and immune responses in vivo.</p>
</div>
</front>
</TEI>
<pmc article-type="research-article" xml:lang="EN"><pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<pmc-dir>properties manuscript</pmc-dir>
<front><journal-meta><journal-id journal-id-type="nlm-journal-id">0110674</journal-id>
<journal-id journal-id-type="pubmed-jr-id">8015</journal-id>
<journal-id journal-id-type="nlm-ta">Virology</journal-id>
<journal-title>Virology</journal-title>
<issn pub-type="ppub">0042-6822</issn>
<issn pub-type="epub">1096-0341</issn>
</journal-meta>
<article-meta><article-id pub-id-type="pmid">18456301</article-id>
<article-id pub-id-type="pmc">2574746</article-id>
<article-id pub-id-type="manuscript">NIHMS50005</article-id>
<article-id pub-id-type="doi">10.1016/j.virol.2008.03.034</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Article</subject>
</subj-group>
</article-categories>
<title-group><article-title>Virus growth and antibody responses following respiratory tract infection of ferrets and mice with WT and P/V mutants of the paramyxovirus Simian Virus 5</article-title>
</title-group>
<contrib-group><contrib contrib-type="author"><name><surname>Capraro</surname>
<given-names>Gerald A.</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Johnson</surname>
<given-names>John B.</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Kock</surname>
<given-names>Nancy D.</given-names>
</name>
<xref ref-type="aff" rid="A2">b</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Parks</surname>
<given-names>Griffith D.</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
<xref ref-type="corresp" rid="cor1">*</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>a</label>
Department of Microbiology and Immunology, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157-1064, USA</aff>
<aff id="A2"><label>b</label>
Department of Pathology/Comparative Medicine, Wake Forest University School of Medicine, Winston-Salem, NC 27157-1064, USA</aff>
<author-notes><corresp id="cor1"><label>*</label>
Corresponding author. Fax: +1 336 716 9928. <italic>E-mail address:</italic>
<email>gparks@wfubmc.edu</email>
(G.D. Parks)</corresp>
</author-notes>
<pub-date pub-type="nihms-submitted"><day>8</day>
<month>5</month>
<year>2008</year>
</pub-date>
<pub-date pub-type="epub"><day>5</day>
<month>5</month>
<year>2008</year>
</pub-date>
<pub-date pub-type="ppub"><day>5</day>
<month>7</month>
<year>2008</year>
</pub-date>
<pub-date pub-type="pmc-release"><day>5</day>
<month>7</month>
<year>2009</year>
</pub-date>
<volume>376</volume>
<issue>2</issue>
<fpage>416</fpage>
<lpage>428</lpage>
<abstract><p id="P1">P/V gene substitutions convert the non-cytopathic paramyxovirus Simian Virus 5 (SV5), which is a poor inducer of host cell responses in human tissue culture cells, into a mutant (P/V-CPI–) that induces high levels of apoptosis, interferon (IFN)-beta, and proinflammatory cytokines. However, the effect of SV5-P/V gene mutations on virus growth and adaptive immune responses in animals has not been determined. Here, we used two distinct animal model systems to test the hypothesis that SV5-P/V mutants which are more potent activators of innate responses in tissue culture will also elicit higher antiviral antibody responses. In mouse cells, in vitro studies identified a panel of SV5-P/V mutants that ranged in their ability to limit IFN responses. Intranasal infection of mice with these WT and P/V mutant viruses elicited equivalent anti-SV5 IgG responses at all doses tested, and viral titers recovered from the respiratory tract were indistinguishable. In primary cultures of ferret lung fibroblasts, WT rSV5 and P/V-CPI– viruses had phenotypes similar to those established in human cell lines, including differential induction of IFN secretion, IFN signaling and apoptosis. Intranasal infection of ferrets with a low dose of WT rSV5 elicited ~500 fold higher anti-SV5 serum IgG responses compared to the P/V-CPI– mutant, and this correlated with overall higher viral titers for the WT virus in tracheal tissues. There was a dose-dependent increase in antibody response to infection of ferrets with P/V-CPI–, but not with WT rSV5. Together our data indicate that WT rSV5 and P/V mutants can elicit distinct innate and adaptive immunity phenotypes in the ferret animal model system, but not in the mouse system. We present a model for the effect of P/V gene substitutions on SV5 growth and immune responses in vivo.</p>
</abstract>
<kwd-group><kwd>Antibody</kwd>
<kwd>Paramyxovirus</kwd>
<kwd>P/V mutant</kwd>
</kwd-group>
<contract-num rid="AI1">P01 AI060642-040002</contract-num>
<contract-num rid="AI1">P01 AI060642-030002</contract-num>
<contract-sponsor id="AI1">National Institute of Allergy and Infectious Diseases Extramural Activities : NIAID</contract-sponsor>
</article-meta>
</front>
</pmc>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Caroline du Nord</li>
</region>
</list>
<tree><country name="États-Unis"><region name="Caroline du Nord"><name sortKey="Capraro, Gerald A" sort="Capraro, Gerald A" uniqKey="Capraro G" first="Gerald A." last="Capraro">Gerald A. Capraro</name>
</region>
<name sortKey="Johnson, John B" sort="Johnson, John B" uniqKey="Johnson J" first="John B." last="Johnson">John B. Johnson</name>
<name sortKey="Kock, Nancy D" sort="Kock, Nancy D" uniqKey="Kock N" first="Nancy D." last="Kock">Nancy D. Kock</name>
<name sortKey="Parks, Griffith D" sort="Parks, Griffith D" uniqKey="Parks G" first="Griffith D." last="Parks">Griffith D. Parks</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV2/Data/Pmc/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000905 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Checkpoint/biblio.hfd -nk 000905 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= CovidV2 |flux= Pmc |étape= Checkpoint |type= RBID |clé= PMC:2574746 |texte= Virus growth and antibody responses following respiratory tract infection of ferrets and mice with WT and P/V mutants of the paramyxovirus Simian Virus 5 }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Checkpoint/RBID.i -Sk "pubmed:18456301" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Checkpoint/biblio.hfd \ | NlmPubMed2Wicri -a CovidV2
This area was generated with Dilib version V0.6.33. |